Leerink Partners Remains Bullish as Fate Therapeutics (FATE) Plans to Initiate ProTmune Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Leerink Partners Remains Bullish as Fate Therapeutics (FATE) Plans to Initiate ProTmune Study

Fate Therapeutics (FATE) Tops Q4 EPS by 1c

March 3, 2016 4:15 PM EST

Fate Therapeutics (NASDAQ: FATE) reported Q4 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $580 thousand.

Cash and cash equivalents as of December 31, 2015 were $64.8 million, compared to $49.1 million as of December... More

Trading Radar for 3/3: Barnes & Noble (BKS), Ciena (CIEN), HP Enterprise (HPE), H&R Block (HRB), Trina Solar (TSL) Report

March 2, 2016 3:00 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EST

Initial Claims - Street sees 270kContinuing Claims - Street sees 2.258MProductivity: Rev. - Street sees (3.3%)Unit Labor Costs: Rev. - Street sees 4.7%

Earnings:

Ability, Inc. (Nasdaq: ABIL) - consensus EPS $0.09
Agenus (Nasdaq: AGEN) - consensus loss $0.17
Alaska Communications Systems (Nasdaq: ALSK) - consensus loss $0.01
Ameresco (Nasdaq:... More